New Insights from Rodent Models of Fatty Liver Disease-Reference-Cited by-同舟云学术

New Insights from Rodent Models of Fatty Liver Disease

Published:2011-07-15 Issue:2 Volume:15 Page:535-550
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Maher Jacquelyn J.¹

Affiliation:

1. Liver Center and Department of Medicine, University of California, San Francisco San Francisco, California.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2010.3749

Reference141 articles.

1. Thioredoxin-Binding Protein-2 Deficiency Enhances Methionine-Choline Deficient Diet-Induced Hepatic Steatosis But Inhibits Steatohepatitis in Mice

2. Resveratrol alleviates alcoholic fatty liver in mice

3. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice

4. Fat Aussie—A New Alström Syndrome Mouse Showing a Critical Role for ALMS1 in Obesity, Diabetes, and Spermatogenesis

5. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease;Translational Gastroenterology and Hepatology;2021-01

2. Developmental changes in hepatic lipid metabolism of chicks during the embryonic periods and the first week of posthatch;Poultry Science;2020-03

3. Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications;Acta Pharmaceutica Sinica B;2020-01

4. Role of gut microbiota in liver disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2020-01-01

5. Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease;Current Pharmaceutical Biotechnology;2019-04-30